Patents by Inventor Alessandra Boe

Alessandra Boe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TNF receptor and steroid hormone in a combined therapy
    Publication number: 20060142197
    Abstract: The present invention relates to the use of a TNF Receptor together with a steroid hormone to produce a pharmaceutical composition for the treatment of lethal bacterial and viral infections as well as autoimmune and inflammatory diseases. It also relates to said pharmaceutical compositions for the simultaneous separate or sequential use of its active ingredients for the above specified treatment. In particular, it relates to the use of TBP-1, together with dehydroepiandrosterone (DHEA) or its metabolites to produce a pharmaceutical composition for the treatment of septic shock.
    Type: Application
    Filed: February 13, 2006
    Publication date: June 29, 2006
    Applicant: Applied Research Systems ARS Holding N.V.
    Inventors: Alessandra Boe, Francesco Borrelli
  • TNF receptor and steroid hormone in a combined therapy
    Patent number: 7012060
    Abstract: The present invention relates to the use of a TNF Receptor together with a steroid hormone to produce a pharmaceutical composition for the treatment of lethal bacterial and viral infections as well as autoimmune and inflammatory diseases. It also relates to said pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified treatment. In particular, it relates to the use of TBP-1 together with dehydroepiandrosterone (DHEA) or its metabolites to produce a pharmaceutical composition for the treatment of septic shock.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: March 14, 2006
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Alessandra Boe, Francesco Borrelli
  • TNF receptor and steroid hormone in a combined therapy
    Patent number: 6225300
    Abstract: The present invention relates to the use of a TNF Receptor together with a steroid hormone to produce a pharmaceutical composition for the treatment of lethal bacterial and viral infections as well as autoimmune and inflammatory diseases. It also relates to said pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified treatment. In particular, it relates to the use of TBP-1 together with dehydroepiandrosterone (DHEA) or its metabolites to produce a pharmaceutical composition for the treatment of septic shock.
    Type: Grant
    Filed: February 27, 1998
    Date of Patent: May 1, 2001
    Assignee: Applied Research Systems ARS Holding NV
    Inventors: Alessandra Boe, Francesco Borrelli